96682 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links Dipeptides
Sub-classes:Method for Synthesizing Amide and/or Polypeptide Using Unprotected Amino Acid as Ammonia Component
#2DIPEPTIDOMIMETICS AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES
#3AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#4SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES
#5PURIFICATION METHOD FOR IMIDAZOLE DIPEPTIDES
#6INHIBITORS OF HUMAN EPIDIDYMUS PROTEIN 4
#7SMAC mimetic
#8DISULFIDE BOND CONTAINING COMPOUNDS AND USES THEREOF
#9CYCLIC PEPTIDES AS PROTEIN TARGETING AGENTS
#10HETEROBIFUNCTIONAL MONODISPERSED POLYETHYLENE GLYCOL HAVING PEPTIDE LINKER
#11FUSED 1,4-DIAZEPINES AS BET PROTEIN DEGRADERS
#12FLUORESCENT PROBE FOR USE IN DETECTION OF BRAIN TUMOR
#13SPLIT INTEIN AND PREPARATION METHOD FOR RECOMBINANT POLYPEPTIDE USING THE SAME
#14PEA PEPTIDE WITH AUXILIARY HYPOGLYCEMIC FUNCTION AND PREPARATION METHOD THEREOF
#15METHOD FOR PREPARING DRUG-LINKER MC-MMAF FOR ANTIBODY DRUG CONJUGATE, AND INTERMEDIATES THEREIN
#16Dipeptidomimetics as inhibitors of human immunoproteasomes
#17Molecular imprinted polymers targeting phenylalanine
#18METHOD OF PRODUCING IMIDAZOLE DIPEPTIDES
#19Cyclic peptides as protein targeting agents
#20Aromatic-cationic peptides and uses of same
#21Proteolysis Targeting Chimera Compounds and Methods of Preparing and Using Same
#22SMAC mimetic
#23Disulfide bond containing compounds and uses thereof
#24ANTIMICROBIAL PEPTIDOMIMETICS
#25A CO-AMORPHOUS FORM OF A SUBSTANCE AND A DIPEPTIDE
#26Molecular imprinted polymers targeting phenylalanine
#27USE OF Y PEPTIDE IN PREPARATION OF DRUG OR HEALTHCARE PRODUCT FOR LOWERING BLOOD PRESSURE
#28N-acetylated and non-acetylated dipeptides containing arginine to reduce the viscosity of viscous compositions of therapeutic polypeptides
#29PRODRUG OF AN ICE INHIBITOR
#30Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
#31Engineered alanyl-glutamine dipeptide biosynthetic enzyme and application thereof
#32DIPEPTIDYL KETOAMIDE COMPOUNDS AND THEIR USE FOR THE TREATMENT AND/OR PREVENTION OF FAT ACCUMULATION
#33Substituted boric acid compound, pharmaceutical composition comprising same, and application thereof
#34Fused 1,4-diazepines as BET protein degraders
#35SMAC mimetic
#36Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
#37IMMUNE-STIMULATING PEPTIDES AND CHECKPOINT INHIBITORS, AND USES THEREOF FOR TREATING CANCER
#38N-lipoic-amino acid or peptide, derivatives and their uses
#39Protease transition state inhibitor prodrugs
#40Dipeptide comprising a non-proteogenic amino acid
#41Derivatives of Xanthone Compounds
#42AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#43Bifunctional cytotoxic agents
#44PRODRUG OF AN ICE INHIBITOR
#45SMAC mimetic
#46Dipeptidyl ketoamide compounds and their use for the treatment and/or prevention of fat accumulation
#47Dipeptidomimetics as inhibitors of human immunoproteasomes
#48Method for producing alpha-form crystal of reduced glutathione, and method for storing said crystal
#49Compounds as tyrosine kinase modulators
#50Derivatives of 1-amino-2-cyclobutylethylboronic acid
#51TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
#52CYCLIC DIPEPTIDE-CONTAINING COMPOSITION
#53Hydroxystatin derivatives for the treatment of arthrosis
#54Sulfonamide-containing linkage systems for drug conjugates
#55Prodrug of an ICE inhibitor
#56Antiparisitic dihydroazole compounds and compositions comprising same
#57Substrate-mimetic AKT inhibitor
#58COMPOUNDS AS TYROSINE KINASE MODULATORS
#59Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors
#60Tubulysin compounds, methods of making and use
#61Compounds for binding to the platelet specific glycoprotein IIb/IIIa and their use for imaging of thrombi
#62Process for preparing eptifibatide
#63Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors
#64Compounds for enzyme inhibition
#65NOVEL ANTIMICROBIAL AGENTS
#66Solomonamide analogue compounds, pharmaceuticals containing solomonamide analogue compounds, and processes for the preparation thereof
#67Prodrug of an ice inhibitor
#68Hydroxystatin derivatives for the treatment of arthrosis
#69Benzylamine derivatives as inhibitors of plasma kallikrein
#70Modulators of pharmacokinetic properties of therapeutics
#71Bifunctional cytotoxic agents
#72ANGIOTENSIN-CONVERTING-ENZYME INHIBITING DIPEPTIDE
#73Antiparisitic dihydroazole compounds and compositions comprising same
#74Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#75SMAC Mimetic for Treating Myelodysplastic Syndromes
#76Tubulysin compounds, methods of making and use
#77Daptomycin analogues and a method for the preparation of daptomycin or a daptomycin analogue
#78Dipeptide mimetics of NGF and BDNF neurotrophins
#79Compositions Containing, Methods Involving, and Uses of Non-Natural Amino Acid Linked Dolastatin Derivatives
#80Cyclic peptides as protein targeting agents
#81BORONIC ESTER AND ACID COMPOUNDS, SYNTHESIS AND USES
#82Repeat variable diresidues for targeting nucleotides
#83Methods of treating necrotizing enterocolitis by administering nuclear oligomerization domain-2 agonists,TLR9 agonists and TLR4 antagonists
#84Heteroaryl pyridone and aza-pyridone amide compounds
#85Substrate-mimetic Akt inhibitor
#86Inhibitors of hepatitis C virus replication
#87Dipeptide Comprising a Non-Proteogenic Amino Acid
#88Immunoconjugates, compositions for making them, and methods of making and use
#89DERIVATIVES OF XANTHONE COMPOUNDS
#90Novel N-Benzylamide Substituted Derivatives of 2-(Acylamido)acetic Acid and 2-(Acylamido)propionic Acids: Potent Neurological Agents
#91Compounds as tyrosine kinase modulators
#92METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES
#93METHODS OF TREATMENT OF CELL PROLIFERATIVE AND/OR OPHTHALMIC DISEASES, DISORDERS AND CONDITIONS USING INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY
#94Modulators of protease activated receptors
#95Antiparisitic dihydroazole compounds and compositions comprising same
#96Anti-viral compounds
#97Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi
#98DPP-4 inhibitor
#99Peptidomimetics and their application
#100AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#101Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#102COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION
#103Pyrrolobenzodiazepines
#104Tubulysin compounds, methods of making and use
#105Tubulysin compounds, methods of making and use
#106Benzylamine derivatives as inhibitors of plasma kallikrein
#107Anti-malarial compounds from marine natural products
#108Derivatives of 1-amino-2-cyclobutylethylboronic acid
#109Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
#110Antagonizing Heparin With Salicylamide Compounds And Histamine Blocking Agents
#111Novel Binder-Drug Conjugates (ADCs) and Use of Same
#112Smac mimetic dimers and trimers useful as anti-cancer agents
#113Induction of the mitochondrial permeability transition
#114Active agent prodrugs with heterocyclic linkers
#115Method for Producing Lanthionine Derivative
#116COMPOUNDS FOR ENZYME INHIBITION
#117Beta amino acid derivatives as integrin antagonists
#118Prodrug of an ice inhibitor
#119Serine protease inhibitors
#120Pharmaceutical Compositions of Growth Hormone Secretagogue Receptor Ligands
#121CATIONIC LIPIDS, METHODS FOR PREPARING THE SAME, AND DELIVERY SYSTEMS HAVING ABILITY TO TRANSITION INTO CELLS COMPRISING THE SAME
#122Binder-drug conjugates (ADCs) and use thereof
#123NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#124Compounds for enzyme inhibition
#125Compounds for enzyme inhibition
#126Compounds for enzyme inhibition
#127Stable formulations of a hyaluronan-degrading enzyme
#128SMAC mimetic
#1293,8-diaminotetrahydroquinoline derivative
#130Stable formulations of a hyaluronan-degrading enzyme
#131Immunoconjugates, compositions for making them, and methods of making and use
#132Process for producing dipeptides or dipeptide derivatives
#133Method for preparing lipopeptide compound
#134-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
#135Enzymatic substrates for multiple detection systems
#136SMAC MIMETEC
#137Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#138Compounds for enzyme inhibition
#139Inhibitors of hepatitis C virus replication
#140Use of toll-like receptor-9 agonists
#141Rapid FRET-based diagnosis of bacterial pathogens
#142Method and compositions for treating amyloid-related diseases
#143DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS
#144Boronic ester and acid compounds, synthesis and uses
#145Prodrug of an ICE inhibitor
#146Selected inhibitors of protein tyrosine kinase activity
#147Inhibitors of protein tyrosine kinase activity
#148Modulators of pharmacokinetic properties of therapeutics
#149Anti-viral compounds
#150Antiparisitic dihydroazole compounds and compositions comprising same
#151Anti-Viral Compounds
#152N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
#1532-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
#1543,8-diaminotetrahydroquinoline derivative
#155Anti-viral compounds
#156BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM
#157Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it
#158Vapor deposition of biomolecules
#159THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES
#160DIMERIC IAP INHIBITORS
#161Compounds for enzyme inhibition
#162Compounds for enzyme inhibition
#163Pseudoproline dipeptides
#164Derivatives of 1-amino-2-cyclobutylethylboronic acid
#165Substrate-mimetic Akt inhibitor
#166Modulators of pharmacokinetic properties of therapeutics
#167Phosphonyl ester conjugates as prodrugs
#168Enzymatic substrates for multiple detection systems
#169Boronic ester and acid compounds, synthesis and uses
#170Peptide derivatives with therapeutic activity
#171Smac mimetic dimers and trimers useful as anti-cancer agents
#172Prodrug of an ICE inhibitor
#173Method for producing tripeptides and/or peptides longer than tripeptides
#174Selective inhibitors of neurotensin degrading enzymes
#175Boronic ester and acid compounds, synthesis and uses
#176Modulators of pharmacokinetic properties of therapeutics
#177Pseudo proline dipeptides
#178Compounds for enzyme inhibition
#179Boronic ester and acid compounds, synthesis and uses
#180Process for Producing Dipeptides
#181Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
#182Methods and compositions for treating amyloid-related diseases
#183Bile-acid conjugates providing for sustained systemic concentration of drugs
#184Induction of the mitochondrial permeability transition
#185Boronic ester and acid compounds, synthesis and uses
#186Cidofovir peptide conjugates as prodrugs
#187Bile-acid conjugates for providing sustained systemic concentrations of drugs
#188Process for producing dipeptides or dipeptide derivatives
#189N-methyl amino acids
#190Inhibitors of dipeptidyl peptidase I
#191Bile-acid conjugates providing for sustained systemic concentration of drugs